Fadia Moustafa Attia

Fadia Moustafa Attia

Auto-generated profile, based on publicly available information

Fadia Moustafa Attia

Department of Clinical Pathology Suez Canal University Ismailia Egypt

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

19 January 2010 in Scandinavian Journal of Infectious Diseases
Verified
Journal Article
Closed access
PDF file
AZAlaa A.H. Zeitoun
Alaa A.H. Zeitoun
SGSuzan S. Gad
Suzan S. Gad
FAFadia M. Attia
Fadia M. Attia
AMAsmaa S. Abu Maziad
Asmaa S. Abu Maziad
EBEdward F. Bell
Edward F. Bell
The assay of infection markers can improve diagnostic sensitivity in neonatal sepsis. We determined the levels of neutrophilic CD64 (nCD64), procalcitonin (PCT) and interleukin 10 (IL-10) in infants with neonatal sepsis. Forty-nine newborn infants who met the criteria of sepsis were subjected to a routine sepsis evaluation as well as measurement of PCT and IL-10 levels and nCD64 expression. Of these 49 ‘infected’ infants, 16 had a positive blood culture (culture-positive sepsis) and 33 infants were diagnosed to have clinical sepsis with negative blood cultures (culture-negative sepsis). Another 49 healthy newborn infants were included as a control group. The sensitivity, specificity, positive predictive value and negative predictive value of PCT, IL-10 and nCD64 for the diagnosis of sepsis were determined. IL-10 had the highest sensitivity of 92% and specificity of 84% using a cut-off of ≥17.3 pg/ml. For PCT, the highest sensitivity of 65% and specificity of 60% were found at a cut-off value of ≥36.4 pg/ml. nCD64 had a maximal sensitivity of 92% and specificity of 71% at a cut-off value of 2.6%. Combinations of different markers may improve the sensitivity and specificity of biomarker tests. We found that the best combination was IL-10 and nCD64, which together provided sensitivity of 95% and specificity of 83%, and a negative predictive value of 86%.

15 February 2012 in Journal of Medical Virology
Verified
Journal Article
Closed access
PDF file
MRMostafa Ragheb
Mostafa Ragheb
AEAbeer Elkady
Abeer Elkady
YTYasuhito Tanaka
Yasuhito Tanaka
SMShuko Murakami
Shuko Murakami
FAFadia M. Attia
Fadia M. Attia
MMMasashi Mizokami
Masashi Mizokami

18 August 2020 in Clinical and Experimental Dermatology
Verified
Journal Article
Closed access
PDF file
RMR. El‐Sayed Mahmoud Marie
R. El‐Sayed Mahmoud Marie
GEG. A. K. El‐Sayed
G. A. K. El‐Sayed
FAF. M. Attia
F. M. Attia
AGA. H. A. Gomaa
A. H. A. Gomaa

1 November 2011 in Archives of Pathology & Laboratory Medicine
Verified
Journal Article
Closed access
FAFadia M. Attia
Fadia M. Attia
AMAhmed Maaty
Ahmed Maaty
FKFawzy Attia Kalil
Fawzy Attia Kalil
Context .—Systemic lupus erythematosus (SLE) is associated with an increased risk of atherosclerosis; endothelial dysfunction represents the first step in its pathogenesis. Objective .—To assess endothelial dysfunction in SLE by circulating endothelial cells (CECs) and to characterize SLE-specific factors that contribute to its appearance. Design .—Case-control study was conducted on 60 subjects, divided into 2 groups: group A (30 patients with SLE) and group B (30 healthy sex- and age-matched controls). Total cholesterol, triglycerides, antinuclear antibodies, anti–double-stranded DNA antibodies, and C3 were determined in all patients. Systemic lupus erythematosus activity was assessed using the SLE Disease Activity Index. Endothelial function was assessed by means of flow-mediated dilation of the brachial artery using B-mode ultrasonography and relative quantification of CD 146 mRNA by real-time polymerase chain reaction. Results .—The group of SLE patients was formed of 20 females and 10 males, with a mean age of 31.16 ± 9.69 years. The values of SLE-specific tests and SLE Disease Activity Index were represented by anti–double-stranded DNA antibodies 160 ± 40.5, C3 68.91 ± 11.91 mg/dL, total cholesterol 188.66 ± 49.63 mg/dL, triglycerides 143.41 ± 46.26 mg/dL, and SLE Disease Activity Index 12.66 ± 3.70. Values for flow-mediated dilation were 8.85% ± 2.02% (group A) and 20.33% ± 6.19% (group B), P < .001, and CECs were 300 ± 40.5 μL −1 blood (group A) and 10 ± 2.5 μL −1 blood (group B). The statistical analysis showed a strong inverse correlation between CECs and SLE Disease Activity Index, a strong correlation between CECs and C3, a strong correlation between CECs and anti–double-stranded DNA antibodies, and a moderate inverse correlation between CECs and total cholesterol. Conclusion .—Endothelial dysfunction is present in SLE patients even in the absence of traditional cardiovascular risk factors due to disease activity.

21 October 2009 in The Open Cardiovascular Medicine Journal
Verified
Journal Article
Open access
FAF.M. Attia
F.M. Attia
DMD.P. Mikhailidis
D.P. Mikhailidis
SRS.A. Reffat
S.A. Reffat
Aim: The pathogenesis of deep venous thrombosis (DVT) involves an interaction between hereditary and acquired factors. Prothrombin gene mutation is one of the hereditary risk factors. We evaluated the frequency of the prothrombin gene mutation in patients with DVT and its relation to oral warfarin anticoagulant therapy response.Methods: Prothrombin gene mutation was looked for in 40 DVT patients with poor response to warfarin. The results were compared with 40 DVT patients with a normal response to warfarin and 30 healthy blood donors. Blood samples were also assessed for protein C, protein S, anti-thrombin III and anticardiolipin antibodies (ACA) levels.Results: Prothrombin gene mutation was found in normal and poor DVT responders (6/40 and 13/40, respectively; p = NS) as well as in healthy controls (1/30). Patients with recurrent DVT or a family history of DVT were significantly (p<0.0001) more likely to have the prothrombin mutation than other DVT patients. Non prothrombin abnormalities (protein C, anti-thrombin III and ACA) were more common in poor responders than controls (p<0.0037) as were ACA (p<0.034).Conclusions: Prothrombin gene mutation is present in several DVT patients, especially those with recurrent DVT or a family history of DVT. This mutation may contribute to a poor response to warfarin.